Serina Therapeutics (SER) Times Interest Earned (2018 - 2026)
Serina Therapeutics (SER) posted Times Interest Earned of -$36.09 for Q4 2025, up 86.45% sequentially from -$266.33 in Q3 2025, and down 134.12% YoY from $105.76 in Q4 2024.
Serina Therapeutics (SER) Times Interest Earned (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Times Interest Earned for 8 years, with the latest figure at -$36.09 in Q4 2025.
- Quarterly Times Interest Earned fell 134.12% year-over-year to -$36.09 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$54.84 (down 20.32% YoY) and the FY2025 annual result came in at -$0.54, up 98.32% from the prior year.
- Times Interest Earned grew to -$36.09 in Q4 2025 per SER's latest filing, from -$266.33 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$1.24 in Q4 2023 and troughed at -$551.25 in Q2 2021.
- A 5-year average of -$72.95 and a median of -$12.36 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2022: Times Interest Earned tumbled 5067.97% in 2021, then jumped 99.67% in 2022.
- Over 5 years, Times Interest Earned stood at -$5.87 in 2021, then soared by 71.41% to -$1.68 in 2022, then climbed by 26.02% to -$1.24 in 2023, then tumbled by 1140.79% to -$15.41 in 2024, then sank by 134.12% to -$36.09 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$36.09, -$266.33, and -$14.23 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | 1.42 |
| 10 | Serina Therapeutics | 44.84 Mn | 21.82 Mn | - | -33.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.49 |
| Dec 31, 2025 | -36.09 |
| Sep 30, 2025 | -266.33 |
| Jun 30, 2025 | -14.23 |
| Mar 31, 2025 | -13.53 |
| Dec 31, 2024 | -15.41 |
| Sep 30, 2024 | -45.40 |
| Jun 30, 2024 | -6.28 |
| Mar 31, 2024 | -3.40 |
| Dec 31, 2023 | -1.24 |
| Sep 30, 2023 | -14.63 |
| Jun 30, 2023 | -8.75 |
| Mar 31, 2023 | -11.19 |
| Sep 30, 2022 | -1.68 |
| Jun 30, 2022 | -1.84 |
| Mar 31, 2022 | -3.59 |
| Sep 30, 2021 | -5.87 |
| Jun 30, 2021 | -551.25 |
| Mar 31, 2021 | -312.43 |
| Sep 30, 2020 | -21.79 |